enVVeno Medical Corporation
Industry
- Medical Devices
- Implantable Devices
Other Names/Subsidiaries
- Hancock Jaffe Laboratories, Inc.
Latest on enVVeno Medical Corporation
Hancock Jaffe is changing its name to enVVeno Medical Corporation to reflect its prioritization of technologies for treating venous disease. The name change will take effect on 1 October when the com
Socioeconomic Disparities In TAVR Access Patients with aortic stenosis who live in poorer communities are less likely to be treated with transcatheter aortic valve replacement (TAVR) than patients who
Hancock Jaffe Laboratories will fund a pivotal trial of its VenoValve device to treat lower limb chronic deep venous insufficiency with $41.4m raised in a new public stock offering completed on 11 Fe
[ Editors Note : Starts & Stops is Medtech Insight’ s regular review of important medical device trial announcements as tracked by Informa’s MedDeviceTracker . Click here to request a demonstra